title: Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation.
abstract: Successful therapy of atrial fibrillation (AF) has been reportedly influenced by a variety of factors including patient age, type of underlying heart disease, duration of arrhythmia, left ventricular function and left atrial (LA) size. To determine which of these factors are associated with maintenance of sinus rhythm after conversion, 43 patients with symptomatic chronic AF in the setting of a dilated left atrium (greater than or equal to 45 mm, range 45 to 78) were followed for at least 6 months after the return of sinus rhythm. Class IA drugs, IC drugs or amiodarone were used for therapy. Life table analysis showed sinus rhythm to be maintained in 81% for 6 months, 79% for 12 months and 60% for 24 months. Factors positively associated with success were conversion with drug therapy alone, duration of chronic AF less than or equal to 1 year, absence of mitral valve disease and LA dimension less than or equal to 60 mm (all p less than 0.05). Patient age, left ventricular function and presence of coronary disease were not associated with outcome. Thus, patients with moderate LA dilatation (45 to 60 mm) and a short duration of chronic AF can often be maintained in sinus rhythm, especially if they convert with pharmacologic intervention alone.
authors.affiliation: Department of Medicine, University of California at Irvine, Orange 92668.
authors.forename: M A
authors.initials: MA
authors.lastname: Brodsky
authors.forename: B J
authors.initials: BJ
authors.lastname: Allen
authors.forename: E V
authors.initials: EV
authors.lastname: Capparelli
authors.forename: C R
authors.initials: CR
authors.lastname: Luckett
authors.forename: R
authors.initials: R
authors.lastname: Morton
authors.forename: W L
authors.initials: WL
authors.lastname: Henry
mesh_terms: D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000503:physiopathology* / Q000628:therapy; D002908:Chronic Disease; D004108:Dilatation, Pathologic / Q000150:complications / Q000503:physiopathology; D004452:Echocardiography; D004554:Electric Countershock; D005260:Female; D006325:Heart Atria / Q000473:pathology; D006339:Heart Rate; D006801:Humans; D008297:Male; D008875:Middle Aged; D012008:Recurrence
chemical_list: D000889:Anti-Arrhythmia Agents